Document is current
Any future updates will be listed below
-
Authors
Chen, Haojie
Shi, Bowen
Wu, Yanyuan
Qian, Yuhang
Zhou, Jiatong
Zhang, Xi
Ding, Jie
Yu, Yongjiang https://orcid.org/0000-0002-1186-2197
-
Funding
Funding for this research was provided by:
Clinical Research Plan of SHDC (SHDC2020CR4034)
- License Information
-
More Information
Article History
Received: 19 December 2021
Accepted: 10 January 2022
First Online: 24 February 2022
Declarations
:
: The authors declared no competing interest exists. The Beckman Coulter Ltd. provided reagents for the study and contributed to the repetition detection of serum samples. Beckman Coulter Ltd. played no role in the study design, patient enrollment, data interpretation, or manuscript approval. All authors Consent for publication.
: All procedures performed in this study were following the ethical standards of the Ethics Committee of Xinhua Hospital (XHEC-C-2019-113-2), written informed consent was obtained from each patient. Considering that PHI has not been approved by China Food and Drug Administration, the presented study was only performed as an innovative research program. Serum p2PSA was measured but not used for clinical decisions.
